Coffee and Green Tea Consumption and Subsequent Risk of Acute Myeloid Leukemia and Myelodysplastic Syndromes in Japan

International Journal of Cancer - United States
doi 10.1002/ijc.31135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Coffee and Green Tea Consumption and Subsequent Risk of Malignant Lymphoma and Multiple Myeloma in Japan: The Japan Public Health Center-Based Prospective Study

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2017English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology
Cancer ResearchOncology
2019English

Coffee/Tea Consumption and Depression: A Risk Assessment

British Journal of Nutrition
MedicineNutritionDietetics
2019English

Coffee and Green Tea Consumption in Relation to Brain Tumor Risk in a Japanese Population

International Journal of Cancer
Cancer ResearchOncology
2016English

Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Allogeneic Stem Cell Transplantation in Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Impact of Patient Characteristics and Timing of Transplant

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2011English

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

FLAMSA-RIC for Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy